| PHIN2004-1 | | Active substances | | Holder |
 |
| |
- Substances emerging from pharmacochemical research, part a | | |
|
| |
- Substances emerging from pharmacochemical research, part b | | |
|
| |
- Substances emerging from biotechnology, | | |
|
| |
- Substances of natural origin, part a | | |
|
| |
- Substances of natural origin, part b | | |
|
| |
- Radiopharmaceuticals products, | | |
|
| PHIN2029-2 | | Regulation and the medical-social environment | | Holder |
|
| |
- Economic aspects of drug development | | |
|
| |
- Legislation and procedures applied to pharmaceutical industry, part a : legislation | | |
|
| |
- Legislation and procedures applied to pharmaceutical industry, part b : patents and protection | | |
|
| |
- Macroeconomic environment and pharmaco-economics | | |
|
| |
- CTD File (Common Technical Document) | | |
|
| |
- Regulations of preclinical and clinical studies, part a : pharmaceutical toxicological files | | |
|
| |
- Regulations of preclinical and clinical studies, part b : clinical studies | | |
|
| |
- Regulations of preclinical and clinical studies, part c : pediatric studies | | |
|
| |
- Specific regulatory issues, part a : medicine and herbal dietary supplement | | |
|
| |
- Specific regulatory issues, part b : Preformulation and galenical development documentation | | |
|
